Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study - Concepedia

Concepedia

Publication | Closed Access

Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study

25

Citations

22

References

2019

Year

Kei Ito, Satoshi Kito, Y. Nakajima, Takuya Shimizuguchi, Hiroaki Ogawa, Keiji Nihei, Hiroshi Tanaka, Nao Kino, Toshiharu Yasugi, Katsuyuki Karasawa

Japanese Journal of Clinical Oncology

Abstract

The recommended dose of SBRT boost was 22.5 Gy in three fractions. We plan to conduct a phase II multi-center clinical trial using the methodology obtained from the current study.

References

	Year	Citations

Page 1